Effect of renal insufficiency on the pharmacok... [Diabetes Care. 2007] - PubMed

Save items

loading

Related citations in PubMed

Tolerability and pharmacokinetics of metformin and the dipeptidyl peptidase-4 inhibitor sitagliptin when co-administered in patients with type 2 diabetes. [Curr Med Res Opin. 2006]
Tolerability and pharmacokinetics of metformin and the dipeptidyl peptidase-4 inhibitor sitagliptin when co-administered in patients with type 2 diabetes.
Herman GA, Bergman A, Yi B, Kipnes M, Sitagliptin Study 012 Group. Curr Med Res Opin. 2006 Oct; 22(10):1939-47.
Effect of moderate hepatic insufficiency on the pharmacokinetics of sitagliptin. [Can J Clin Pharmacol. 2009]
Effect of moderate hepatic insufficiency on the pharmacokinetics of sitagliptin.
Migoya EM, Stevens CH, Bergman AJ, Luo WL, Lasseter KC, Dilzer SC, Davies MJ, Wagner JA, Herman GA. Can J Clin Pharmacol. 2009 Winter; 16(1):e165-70. Epub 2009 Feb 16.
Disposition of the dipeptidyl peptidase 4 inhibitor sitagliptin in rats and dogs. [Drug Metab Dispos. 2007]
Disposition of the dipeptidyl peptidase 4 inhibitor sitagliptin in rats and dogs.
Beconi MG, Reed JR, Teffera Y, Xia YQ, Kochansky CJ, Liu DQ, Xu S, Elmore CS, Ciccotto S, Hora DF, et al. Drug Metab Dispos. 2007 Apr; 35(4):525-32. Epub 2007 Jan 12.
Review [Sitagliptin. DPP-4 inhibitors as a useful extension of oral diabetes therapy?]. [Dtsch Med Wochenschr. 2008]
Review [Sitagliptin. DPP-4 inhibitors as a useful extension of oral diabetes therapy?].
Matthes J, Faust M. Dtsch Med Wochenschr. 2008 Oct; 133(43):2233-7. Epub 2008 Oct 15.
Review Sitagliptin, a DPP-4 inhibitor for the treatment of patients with type 2 diabetes: a review of recent clinical trials. [Curr Med Res Opin. 2008]
Review Sitagliptin, a DPP-4 inhibitor for the treatment of patients with type 2 diabetes: a review of recent clinical trials.
Karasik A, Aschner P, Katzeff H, Davies MJ, Stein PP. Curr Med Res Opin. 2008 Feb; 24(2):489-96.

See reviews... See all...

Cited by 13 PubMed Central articles

Present and Prospective Pharmacotherapy for the Management of Patients with Type 2 Diabetes. [Clin Med Ther. 2009]
Present and Prospective Pharmacotherapy for the Management of Patients with Type 2 Diabetes.
Corsino L, Cox ME, Rowel J, Green JB. Clin Med Ther. 2009 Aug 27; 1:1103-1119.
Medicinal Chemistry and Applications of Incretins and DPP-4 Inhibitors in the Treatment of Type 2 Diabetes Mellitus. [Open Med Chem J. 2011]
Medicinal Chemistry and Applications of Incretins and DPP-4 Inhibitors in the Treatment of Type 2 Diabetes Mellitus.
Lotfy M, Singh J, Kalász H, Tekes K, Adeghate E. Open Med Chem J. 2011; 5(Suppl 2):82-92. Epub 2011 Sep 9.
Dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes: safety, tolerability, and efficacy. [Drug Healthc Patient Saf. 2010]
Dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes: safety, tolerability, and efficacy.
Cox ME, Rowell J, Corsino L, Green JB. Drug Healthc Patient Saf. 2010; 2:7-19. Epub 2010 Jan 28.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Recent activity

Clear Turn Off Turn On

Effect of renal insufficiency on the pharmacokinetics of sitagliptin, a dipeptid...
Effect of renal insufficiency on the pharmacokinetics of sitagliptin, a dipeptidyl peptidase-4 inhibitor.
Diabetes Care. 2007 Jul ;30(7):1862-4. Epub 2007 Apr 27 .

PubMed
Carnitine stimulation of glucose oxidation in the fatty acid perfused isolated w...
Carnitine stimulation of glucose oxidation in the fatty acid perfused isolated working rat heart.
J Biol Chem. 1992 Feb 25 ;267(6):3758-63.

PubMed
Correlation between atherosclerosis and periodontal putative pathogenic bacteria...
Correlation between atherosclerosis and periodontal putative pathogenic bacterial infections in coronary and internal mammary arteries.
J Periodontol. 2007 Apr ;78(4):677-82.

PubMed
Tumor necrosis factor impairs insulin action on peripheral glucose disposal and ...
Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output.
Endocrinology. 1992 Jan ;130(1):43-52.

PubMed
Peroxisome proliferator-activated receptors as transcriptional nodal points and ...
Peroxisome proliferator-activated receptors as transcriptional nodal points and therapeutic targets.
Circulation. 2007 Jan 30 ;115(4):518-33.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Effect of renal insufficiency on the pharmacokinetics of sitagliptin, a dipeptidyl peptidase-4 inhibitor.

Source

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Libraries

Supplemental Content

Save items

Related citations in PubMed

Cited by 13 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information